Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian712000Chief Executive Officer & Director
Jeffrey Farber572003Chairman
Martin P. Galvan, CPA652011CFO, Treasurer & Vice President-Finance
Robert Ehlinger602006Chief Information Officer & VP-logistics
David A. Drabik492010Lead Independent Director
Paul Taveira572012Independent Director
James M. Maher642013Independent Director
Albert R. Paonessa III572015Independent Director
Kevin R. Smith572002Senior Vice President-Sales & Marketing
John Abt-2015Vice President-Quality
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,794,694 27,240,112 72.1% 605,202 1.6% 72.1%
Shareholders
NameEquities%
Telemus Capital LLC 6,160,820 16.6%
Jeffrey Farber 4,643,874 12.5%
David Farber 3,779,904 10.2%
BlackRock Fund Advisors 3,414,718 9.19%
The Vanguard Group, Inc. 2,609,670 7.02%
Snow Capital Management LP 2,525,635 6.80%
Invesco PowerShares Capital Management LLC 1,898,649 5.11%
Deerfield Management Company LP 1,853,896 4.99%
LSV Asset Management 1,489,057 4.01%
SSgA Funds Management, Inc. 1,186,674 3.19%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.850
JOHNSON & JOHNSON3.86%325 158
ROCHE HOLDING LTD.5.98%210 992
PFIZER INC.3.51%203 836
NOVARTIS AG3.51%202 566
MERCK & CO., INC.11.23%180 014
SANOFI4.38%109 481
GLAXOSMITHKLINE PLC4.96%101 006
BAYER AG9.86%94 192
BRISTOL-MYERS SQUIBB C..-6.26%92 503
ALLERGAN PLC17.69%92 390
ELI LILLY AND CO9.26%89 497
ABBOTT LABORATORIES17.18%77 777
ASTRAZENECA PLC3.55%71 896
NOVO NORDISK A/S-3.02%71 279
SHIRE PLC3.65%54 775
TAKEDA PHARMACEUTICAL ..10.38%37 222
TEVA PHARMACEUTICAL IN..0.80%36 910
ASTELLAS PHARMA INC-5.90%28 708
MYLAN NV10.88%22 474
CHUGAI PHARMACEUTICAL ..16.24%19 218
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Cranbrook & Co. Llc
Kremers Urban Pharmaceuticals, Inc.
Generic Pharmaceutical Co.
Auburn Pharmaceuticals, Inc.
Grason-Stadler, Inc.
National Response Corp.
The American Institute of Certified Public Accountants
Healthcare Distribution Management Association
Company contact information
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2017 People , Fundamentals and Ownership